Answers are grounded in this paper and cite their sources.
Background Depressive symptoms and gait speed (GS) are inversely associated; however, the bidirectionality of this association remains unclear in maintenance hemodialysis (MHD) patients. This study aims to investigate whether the aforementioned relationship is bidirectional. Methods GS was used as a representative indicator of physical performance and was measured with a 6-meter distance. Depression was assessed with the self-reported Patient Health Questionnaire-9. A multivariable logistic regression model and restricted cubic spline analyses were used to assess the relationship between GS and depression. Subgroup analyses were conducted to explore potential effect modifications and sensitivity analyses were performed to determine the robustness of the results. Results The prevalence of depression and GS impairment was approximately 34% and 49%, respectively. Compared to the reference group, patients in the highest tertiles of GS had an 42% lower [odds ratio (OR) = 0.58, 95% confidence interval (CI) = 0.34–0.99] prevalence of depression after multivariate adjustments. Also, an obvious linear trend was observed ( p trend <0.05). Additionally, the prevalence of depression among MHD patients decreased by 24% (OR = 0.76, 95% CI = 0.61–0.96) for each standard deviation increase in GS. In the fully adjusted model, depression in MHD patients was significantly associated with a 58% increase in GS impairment prevalence (OR = 1.58, 95% CI = 1.04–2.43). Subgroup analyses indicated that the relationship between GS and depression was particularly pronounced among female patients. Sensitivity analyses confirmed that our results were robust. Furthermore, a mutual linear dose-response relationship was observed between GS and the prevalence of depression ( p nonlinearity >0.05). Conclusions The association between GS and depressive symptoms could be bidirectional in MHD patients. These findings highlight the importance of integrating assessments of both physical performance and mental health into routine clinical care for MHD patients. Clinical trial number Not applicable.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: